XXII Stock Price, Chart, Stats & News

22nd Century Group, Inc.
Save
1.62M
Market cap
–
Current P/E
–
Forward P/E
XXII chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -20.24% |
Operating margin | -64.91% |
Pretax margin | -74.74% |
Net margin | -28.74% |
Effective tax rate | 0.21% |
ROA | -18.70% |
ROE | -43.84% |
D/E | 0.27x |
Interest coverage ratio | -7.85x |
XXII valuation
P/E | – |
P/S | 0.02x |
P/B | 0.03x |
P/CF | -0.06x |
P/FCF | -0.05x |
P/OCF | -0.06x |
PEG | -0.00x |
EV multiple | -0.33x |
About
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations.
Similar securities
Based on sector and market capitalization
Report issue











